Condition: HPV Infection · Cervical Cancer · Sponsor: University Hospital, Bordeaux
This study proposes to describe and evaluate the rate of spontaneous regression of CIN2 at 2 year of follow up in women between 18 and 39 year old. This follow-up is proposed as an alternative to the treatment of reference (conization) with a possible extension to 4 years
This description comes directly from the study's public registry record.
Jean-Luc Brun, MD, PhD · 335 56 79 59 85 · jean-luc.brun@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU Bordeaux | Bordeaux, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04057924